Skip to main content

Part of the book series: Issues on Clinical Child Psychology ((ICCP))

Abstract

Epilepsy is a tendency of occurrence of transient recurrent abnormal electrical discharges in the brain affecting one or more of the following brain functions: motor, sensory, cognitive, speech, behavioral, emotional, and psychological. The lifetime prevalence of epilepsy in the general population is between 2 and 3%. The prevalence of epilepsy among people who have mental retardation is much higher. Although it is difficult to determine the exact figure, the reported prevalence of lifetime epilepsy among people with mental retardation (IQ< 70) varies between 13 and 24% (Deb, 1997a; Forsgren, Edvinsson, Blomquist, Heijbel, & Sidenvall, 1990; Goulden, Shinnar, Koller, Katz, & Richardson, 1991; McGrother, Hauck, Bhaumik, Thorp, & Taub, 1996; Rutter, Tizard, Yule, Graham, & Whitmore, 1976).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  • Alvarez, N. (1998). Barbiturates in the treatment of epilepsy in people with intellectual disability. Journal of Intellectual Disability Research, 42(S1), 16–23.

    PubMed  Google Scholar 

  • Alvarez, N., Besag, F., & Livanianen, M. (1998). Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability. Journal of Intellectual Disability Research, 42(S1), 1–15.

    PubMed  Google Scholar 

  • Benedetti, B. D., Dov, I., Hauser, W. A., Shinnar, S., & Cohen, H. J. (1986). Frequency of seizures among children with cerebral palsy and mental retardation. Developmental Medical Child Neurology, 28(Suppl. 53), 36.

    Google Scholar 

  • Ben-Menachem, E. (2000). New antiepileptic drugs and non-pharmacological treatments. Current Opinion in Neurology, 13, 165–170.

    Article  PubMed  Google Scholar 

  • Ben-Menachem, E., Henriksen, O., & Johannessen, S. I. (1999). Diagnosis and treatment of partial seizures. CNS Drugs, 11(1), 23–39.

    Article  Google Scholar 

  • Besag, F. M. C. (1998). Lamotrigine in the treatment of epilepsy in people with intellectual disability. Journal of Intellectual Disability Research, 42(S1), 50–56.

    PubMed  Google Scholar 

  • Betts, T. (1990). Pseudoseizures: Seizures that are not epilepsy. Lancet, 336, 163–164.

    Article  PubMed  Google Scholar 

  • Bhaumik, S., Branford, D., Duggirala, C., & Ismail, I. A. (1997). A naturalistic study of the use of vigabatrin, lamotrigine and gabapentin in adults with learning disabilities. Seizure, 6, 127–133.

    Article  PubMed  Google Scholar 

  • Brodie, M. J., Yuen, A. W. C., & the 105 Study Group. (1997). Lamotrigine substitution study: Evidence for synergism with sodium valproate? Epilepsy Research, 26, 423–432.

    Article  PubMed  Google Scholar 

  • Cataltepe, O., & Comair, Y. G. (1999). Focal resection in the treatment of neuronal migrational disorders. In P. Kotagal & H. O. Lüders (Eds.), The epilepsies: Etiology and prevention (pp. 87–92). San Diego, CA: Academic.

    Google Scholar 

  • Collacott, R. A., Dignon, A., Hauck, A., & Ward, J. W. (1989). Clinical and therapeutic monitoring of epilepsy in a mental handicap unit. British Journal of Psychiatry,155, 522–525.

    PubMed  Google Scholar 

  • Coulter, D. L. (1993). Epilepsy and mental retardation: An overview. American Journal of Mental Retardation, 98, 1–11.

    PubMed  Google Scholar 

  • Deb, S. (1995). Electrophysiological correlates of psychopathology in individuals with mental retardation and epilepsy. Journal of Intellectual Disability Research, 39, 129–135.

    Article  PubMed  Google Scholar 

  • Deb, S. (1997a). Epilepsy and mental retardation. Epilepsie Bulletin, 25, 91–94.

    Google Scholar 

  • Deb, S. (1997b). Structural neuroimaging in mental retardation. British Journal of Psychiatry, 171, 417–419.

    Google Scholar 

  • Deb, S. (1997c). Mental disorder in adults with mental retardation and epilepsy. Comprehensive Psychiatry, 38, 179–184.

    Article  Google Scholar 

  • Deb, S., & Ahmed, Z. (2000). Special conditions leading to mental retardation. In M. G. Gelder, N. Andreasen, & J. J. Lopez-Ibor (Eds.), New Oxford textbook of psychiatry (pp. 1953–1963). Oxford, UK: Oxford Press.

    Google Scholar 

  • Deb, S., & Fraser, W. I. (1994). The use of psychotropic medication in people with learning disability: Towards rational prescribing. Human Psychopharmacology, 9, 259–272.

    Article  Google Scholar 

  • Deb, S., & Hunter, D. (1992). The effect of anticonvulsant medication on the psychopathology of adults with a mental handicap and epilepsy. Human Psychopharmacology, 7, 129–134.

    Article  Google Scholar 

  • Deb, S., & Joyce, J. (1999a). Characteristics of epilepsy in a population bases cohort of adults with learning disability. Irish Journal of Psychological Medicine, 16(1), 5–9.

    Google Scholar 

  • Deb, S., & Joyce, J. (1999b). The use of anti-epileptic medication in a population based cohort of adults with learning disability and epilepsy. International Journal of Psychiatry in Clinical Practice, 3, 129–133.

    Article  Google Scholar 

  • Deb, S., Matthews, T., Holt, G., & Bouras, N. (Eds.). (2001). Practice guidelines for the assessment and diagnosis of mental health problems in adults with intellectual disability. London, UK: Pavilion.

    Google Scholar 

  • Dobyns, W. B., & Truwit, C. L. (1995). Lissencephaly and other malformations of cortical development: 1995 update. Neuropediatrics, 26, 132–147.

    PubMed  Google Scholar 

  • Espie, C. A.,Watkins, J., Duncan, R., Espie, A., Sterrick, M., Brodie, M. J., et al. (2001). Development and validation of the Glasgow Epilepsy Outcome Scale (GEOS): A new instrument for measuring concerns about epilepsy in people with mental retardation. Epilepsia, 42(8), 1043–1051.

    Article  PubMed  Google Scholar 

  • Eubanks, J. H., Puranam, R. S., Kleckner, N., Bettler, B., Heinemenn, B., & McNamara, J. O. (1993). The gene encoding the glutamate receptor subunit GluR5 is located on human chromosome 21q21.1-22. 1 in the vicinity of the gene for familial amyotrophic lateral sclerosis. Proceedings of National Academy of Science (USA), 90, 178–182.

    Article  Google Scholar 

  • Forsgren, L., Edvinsson, S. O., Blomquist, H. K., Heijbel, J., & Sidenvall, R. (1990). Epilepsy in a population of mentally retarded children and adults. Epilepsy Research, 6(3), 234–248.

    Article  PubMed  Google Scholar 

  • Friis, M. L. (1998). Valproate in the treatment of epilepsy in people with intellectual disability. Journal of Intellectual Disability Research, 42(S1), 32–35.

    PubMed  Google Scholar 

  • Gaily, E., Granstrom, M.-L., & Lliukkonen, E. (1998). Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability. Journal of Intellectual Disability Research, 42(S1), 41–45.

    PubMed  Google Scholar 

  • Genton, P., Dravet, C., Bureau, N., Formosa, F., & Mesdjian, E. (1997). Aggravation of severe myoclonic epilepsy of infancy by lamotrigine. Epilepsia, 38(Suppl. 3), 32.

    Article  Google Scholar 

  • Goulden, K. J., Shinnar, S., Koller, H., Katz, M., & Richardson, S. A. (1991). Epilepsy in children with mental retardation: A cohort study. Epilepsia, 32, 690–697.

    PubMed  Google Scholar 

  • Henriksen, O., Bjørnaes, H., & Røste, G. K. (1999). Epilepsy surgery in mental retardation: The role of surgery. In M. Sillanpää, L. Gram, S. I. Johannessen, & T. Tomson (Eds.), Epilepsy and mental retardation (pp. 105–113). Philadelphia, PA: Wrightson Biomedical.

    Google Scholar 

  • Holthausen, H., Tuxhorn, I., Pieper, T., Pannek, H., Lahl, R., & Oppel, F. (1999). Hemispherectomy in the treatment of neuronal migrational disorders. In P. Kotagal & H. O. Lüders (Eds.), The epilepsies: Etiology and prevention (pp. 93–102). San Diego, CA: Academic.

    Google Scholar 

  • Isojärvi, J. I. T., & Tokola, R. A. (1998). Benzodiazepine in the treatment of epilepsy. Journal of Intellectual Disability Research, 42(S1), 80–92.

    PubMed  Google Scholar 

  • Kälväiinen, R. (1998). Tiagabine: A new therapeutic option for people with intellectual disability and partial epilepsy. Journal of Intellectual Disability Research, 42(S1), 63–67.

    Google Scholar 

  • Kerr, M., Scheepers, M., Bowely, C., & Working Group of the International Association of the Scientific Study of Intellectual Disability. (2001). Clinical guidelines for the management of epilepsy in adults with an intellectual disability. Seizure, 10, 401–409.

    Article  Google Scholar 

  • Kerr, M. P. (1998). Topiramate: Uses in people with an intellectual disability who have epilepsy. Journal of Intellectual Disability Research, 42(S1), 74–79.

    PubMed  Google Scholar 

  • Lehesjoki, A.-E., Koskiniemi, M., Sistonen, P., Miao, J., Hästbacka, J., Norio, R., et al. (1991). Localisation of a gene for progressive myoclonus epilepsy to chromosome 21q22. Proceedings of National Academy of Science (USA), 88, 3696–3699.

    Article  Google Scholar 

  • Leppik, J. E., & Wolff, D. L. (1995). The place of felbamate in the treatment of epilepsy. CNS Drugs, 4, 294–301.

    Google Scholar 

  • Li, L. M., Fish, D. R., Sisodiya, S. M., Shorvon, S. D., Alsanjari, N., & Stevens, J. M. (1995). High resolution magnetic resonance imaging in adults with partial or secondary generalised epilepsy attending a tertiary referral unit. Journal of Neurology, Neurosurgery, and Psychiatry, 59, 384–387.

    Article  PubMed  Google Scholar 

  • Linuma, K., Minami, T., Cho, K., Kajii, N., & Tachi, N. (1998). Long term effects of Zonisamide in the treatment of epilepsy in children with intellectual disability. Journal of Intellectual Disability Research, 42(S1), 68–73.

    Google Scholar 

  • Livanianen, M. (1998). Phenytoin: Effective but insidious therapy for epilepsy in people with intellectual disability. Journal of Intellectual Disability Research, 42(S1), 24–31.

    Google Scholar 

  • Lund, J. (1985). Epilepsy and psychiatric disorder in the mentally retarded adults. Acta Psychiatrica Scandinavica, 72, 557–562.

    PubMed  Google Scholar 

  • McGrother, C. W., Hauck, A., Bhaumik, S., Thorp, C., & Taub, N. (1996). Community care for adults with learning disability and their carers: Needs and outcome from the Leicestershire register. Journal of Intellectual Disability Research, 40, 183–190.

    Article  PubMed  Google Scholar 

  • Michelucci, R., Forti, A., Rubboli, G., Plasmati, R., Volpi, L., & Tassinari, C.-A. (1989). Mental retardation and behavioural disturbances related to epilepsy: A review. Brain Dysfunction, 2(1), 3–9.

    Google Scholar 

  • Mikati, M. A., Choueri, R., Khurana, D. S., Riviello, J., Helmers, S., & Holmes, G. (1998). Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability. Journal of Intellectual Disability Research, 42(S1), 57–62.

    PubMed  Google Scholar 

  • Pellock, J. M., & Hunt, P. A. (1996). A decade of modern epilepsy therapy in institutionalised mentally retarded patients. Epilepsy Research, 25, 263–268.

    Article  PubMed  Google Scholar 

  • Ramsay, R. E., & Slater, J. D. (1993). Antiepileptic drugs in clinical development [In J. A. French, M. A. Dichter, & I. E. Leppik (Eds.), New anti-epileptic drug development, preclinical and clinical aspects]. Epilepsy Research, (Suppl. 10), 45–67.

    Google Scholar 

  • Roberts, D.W. (1999). Corpus callosotomy in the treatment of neuronal migrational disorders. In P. Kotagal & H. O. Lüders (Eds.), The epilepsies: Etiology and prevention (pp. 103–112). San Diego, CA: Academic.

    Google Scholar 

  • Rutter, M., Tizard, J., Yule, W., Graham, P., & Whitmore, K. (1976). Research report: Isle of Wight studies 1964–1974. Psychological Medicine, 76, 313–332.

    Article  Google Scholar 

  • Sabaz, M., Cairns, D. R., Lawson, J. A., Bleaseley, A. F., & Bye, A. M. E. (2001). The healthrelated quality of life of children with refractory epilepsy: A comparison of those with and without intellectual disability. Epilepsia, 42(5), 621–628.

    Article  PubMed  Google Scholar 

  • Schachter, S. C., & Wheless, J. W. (2002). Vagus nerve stimulation therapy 5 year after approval: A comprehensive update. Neurology, 59(6, Suppl. 4), S1-S61.

    PubMed  Google Scholar 

  • Scheepers, M., Scheepers, B., & Clough, P. (1998). Midazolam via the intranasal route: An effective rescue medication for severe epilepsy in adults with learning disability. Seizure, 7, 509–512.

    Article  PubMed  Google Scholar 

  • Shepherd, C., & Hosking, G. (1989). Epilepsy in school children with intellectual impairment in Sheffield: The size and nature of the problem and its implications in service provision. Journal of Mental Deficiency Research, 33, 511–514.

    PubMed  Google Scholar 

  • Sillanpää, M. (1973). Medico-social prognosis of children with epilepsy. Epidemiological study and analysis of 245 cases. Acta Paediatrica Scandinavica, (Suppl. 237), 1–104.

    Google Scholar 

  • Sillanpää, M. (1999). Definitions and epidemiology. In M. Sillanpää, L. Gram, S. I. Johannessen, & T. Tomson (Eds.), Epilepsy and mental retardation (pp. 1–6). Philadelphia, PA: Wrightson Biomedical.

    Google Scholar 

  • Stafstorm, C. E. (1999). Mechanisms of epilepsy in mental retardation: Insight from Angelman syndrome, Down syndrome and fragile X syndrome. In M. Sillanpää, L. Gram, S. I. Johannessen, & T. Tomson (Eds.), Epilepsy and mental retardation (pp. 7–40). Philadelphia, PA: Wrightson Biomedical.

    Google Scholar 

  • Steffenburg, U., Hagberg, G., & Kyllerman, M. (1996). Characteristics of seizures in a population-based series of mentally retarded children with active epilepsy. Epilepsia, 37, 850–856.

    Article  PubMed  Google Scholar 

  • Suzuki, H., Aihara, M., & Sugai, K. (1991). Severely retarded children in a defined area of Japan: Prevalence rate, associated disabilities and causes. Brain and Development, 23, 4–8.

    PubMed  Google Scholar 

  • Trevathan, E., Murphy, C. C., & Yeargin-Allsopp, M. (1997). Prevalence and descriptive epidemiology of Lennox–Gastaut syndrome among Atlanta children. Epilepsia, 38, 1283–1288.

    Article  PubMed  Google Scholar 

  • Weisburg, H., & Alvarez, N. (1998). Carbamazepine in the treatment of epilepsy in people with intellectual disability. Journal of Intellectual Disability Research, 42(S1), 36–40.

    Google Scholar 

  • Wisniewski, K. E., French, J. H., Fernando, S., Brown, W. T., Jenkins, E. C., Friedman, E., et al. (1985). Fragile X syndrome: Associated neurological abnormalities. Annals of Neurology, 18, 665–669.

    Article  PubMed  Google Scholar 

  • Ylinen, A. (1998). Antiepleptic efficacy of Vigabatrin in people with severe epilepsy and intellectual disability. Journal of Intellectual Disability Research, 42(S1), 46–49.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer

About this chapter

Cite this chapter

Deb, S. (2007). Epilepsy in People With Mental Retardation. In: Jacobson, J.W., Mulick, J.A., Rojahn, J. (eds) Handbook of Intellectual and Developmental Disabilities. Issues on Clinical Child Psychology. Springer, Boston, MA. https://doi.org/10.1007/0-387-32931-5_4

Download citation

Publish with us

Policies and ethics